In a new copyright filing at the European Union Intellectual Property Office (EUIPO) from January 30th, Stellantis has reserved exclusive rights to apply the Fulvia name to, “powered vehicles ...

We preselected all newsletters you had before unsubscribing.

Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada – the first international trial of the technology.

The order would remain in force for two months from the date of its issuance unless revoked earlier. Authorities have extended by two more months the ban on the sale, possession and consumption of ...

Brain computer interface (BCI) company Neuralink has been given regulatory approval to start a new trial of its implant to see if it can be used to control a robotic arm. If it proves to be ...

In January 2024, Elon Musk's neurotechnology company, Neuralink, conducted their first human trial. The first-ever patient was a 29-year-old man named Noland Arbaugh, who had been paralyzed.

Neuralink is celebrating its first year of "Telepathy" involving human trials with its innovative brain-computer interface, ...